STVN
Stevanato Group SpANYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$4.42B
P/E Ratio
26.97
EPS
$0.60
Beta
0.62
52W High
$28.00
52W Low
$12.89
50-Day MA
$15.02
200-Day MA
$20.84
Dividend Yield
0.00%
Profit Margin
11.80%
Forward P/E
19.46
PEG Ratio
3.57
About Stevanato Group SpA
Stevanato Group SpA (STVN) is a prominent global leader in advanced drug delivery systems, offering innovative integrated solutions specifically designed for the pharmaceutical and biotechnology industries. The company specializes in the design and production of high-quality glass and polymer packaging for injectable medications, enhancing the efficiency and reliability of drug administration. With a dedicated focus on quality, sustainability, and technological advancement, Stevanato is strategically positioned to capitalize on the increasing demand within the biopharmaceutical sector, making it an appealing investment opportunity for institutional investors seeking exposure to healthcare innovation.
Fundamentals
| Revenue (TTM) | $1.19B |
| Gross Profit (TTM) | $346.20M |
| EBITDA | $283.56M |
| Operating Margin | 20.90% |
| Return on Equity | 9.67% |
| Return on Assets | 5.23% |
| Revenue/Share (TTM) | $4.35 |
| Book Value | $6.37 |
| Price-to-Book | 2.54 |
| Price-to-Sales (TTM) | 3.72 |
| EV/Revenue | 3.466 |
| EV/EBITDA | 14.47 |
| Quarterly Earnings Growth (YoY) | 0.30% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $49.71M |
| Float | $48.95M |
| % Insiders | 1.58% |
| % Institutions | 107.63% |
Historical Volatility
HV 10-Day
44.28%
HV 20-Day
34.95%
HV 30-Day
37.36%
HV 60-Day
60.20%
HV Rank
5.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($24.72 target)
2
Strong Buy6
Buy2
HoldData last updated: 4/28/2026